Migraine prevention is one of the most important issues facing Migraineurs who experience frequent and / or debilitating Migraine attacks. The vast majority of medications in use for Migraine prevention (more than 100 medications) are prescribed off-label. That means that they're approved for use by the U.S. Food and Drug Administration (FDA), but not specifically for the prevention of Migraine. This is a quite common practice, not only in treating Migraine, but for other conditions as well.
Read moreFull Question: I am on the 25th day of migraine. I take Imitrex 100mg tablets for the pain. I saw my neurologist on day 10 and he... Read more »
For all of you who are using Topamax for Migraine and headache prevention, there's good news. Generic topiramate has been approved by the... Read more »
Our readers ask some great questions about Migraine disease and other headache disorders here on MyMigraineConnection. Nancy and I both... Read more »
Full Question: I have been on Topamax for menstrual migraine for 18 months and it has literally saved my life. My bi-monthly migraines are... Read more »
Full Question: I have what was called "silent" migraines with numbness in face, vision problems, auras, sometimes stomach is upset, and... Read more »
The U.S. Food and Drug Administration has approved the first generic versions of Topamax tablets (topiramate) to prevent seizures. The Topiramate ... Read more »
The following is a copy of a letter sent to healthcare professionals following an FDA MedWatch warning about decreased sweating as a potentially... Read more »
Topiramate is a neuronal stabilizing agent (aka anticonvulsant medication) that has proven effective as a Migraine preventive for some patients. It... Read more »
With Topamax being used for Migraine and headache prevention, many of us eagerly awaited the release of the generic topiramate. However, since the ... Read more »
A study published in the July 22, 2008, issue of Neurology®, indicates that taking the neuronal stabilizing agent (epilepsy drug) Topamax... Read more »